Sterling Capital Management’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
Other funds holding UNCY
CPIG
PFSRSONJ
SO
SS
TFM
FFO
BWL
Sterling Capital Management's UNCY Position: Q2 2026 in Review
Sterling Capital Management opened a new position in Unicycive Therapeutics (UNCY) in Q2 2026: 135 shares worth $633. The stake represents ﹤0.01% of the portfolio and ranks #3202 among its holdings.
10 funds tracked by Wall St. Rank hold UNCY as of Q2 2026.
- Sterling Capital Management held 135 shares of Unicycive Therapeutics worth $633 as of Q2 2026.
- Unicycive Therapeutics was a new Sterling Capital Management position in Q2 2026.
- Unicycive Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3202 holding.
- 10 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q2 2026.
Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.